Sign In
Buy GLP
$49.26
+1.26 (+2.63%)
At Close: Jun 02, 2026
Filing seeks to extend EL-22 myostatin-engineered probiotic platform into pharmaceutical applications for muscle preservation in patients on GLP-1 receptor agonists and across multiple muscle-wasting
Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance Means
09:55am, Tuesday, 28'th Apr 2026
GLP-1 seller Hims & Hers Health NYSE: HIMS has seen significant volatility in its stock price as of late. Notably, despite seeing a 41% single-day surge in early March, HIMS remains down nearly 10% in
Company announcement – No. 10 / 2026 Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful met
GLP-1 pill race heats up as Wegovy tablet holds strong against Lilly rival
10:15am, Monday, 27'th Apr 2026
Novo Nordisk's (NYSE:NVO) Wegovy pill, the oral version of its blockbuster GLP-1 (glucagon-like peptide-1) weight-loss treatment, is tracking at roughly twice the prescription volumes of Eli Lilly's c
3 Top Refining & Marketing MLPs to Buy for Growth Ahead
09:31am, Friday, 24'th Apr 2026
Following a careful analysis of the Zacks Oil and Gas - Refining & Marketing MLP industry. we advise buying three stocks: GLP, SPH and CAPL.
Global Partners LP to Host First-Quarter 2026 Financial Results Conference Call on May 8, 2026
08:30am, Friday, 24'th Apr 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Global Partners LP (NYSE: GLP) (“Global Partners” or the “Partnership”) today announced that it will release its first-quarter 2026 financial results before th
GLP-compliant program covering rodents, non-rodents, and primates will define safety, MTD and safe dose ranges, targeting weight loss and TIIDM Novel Ibogaine formulation development for mental health
West Pharmaceutical Lifts Annual Guidance After Strong GLP-1 Driven Growth In Q1
01:42pm, Thursday, 23'rd Apr 2026
West Pharmaceutical Services, Inc. (NYSE:WST) shares surged Thursday after the company's first-quarter 2026 earnings surpassed analyst estimates.
Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs
09:05am, Thursday, 23'rd Apr 2026
Contracts signed for Animal Study #2: GLP-1-A26-2 Amycretin and retatrutide to be tested for compatibility with DehydraTECH KELOWNA, BC / ACCESS Newswire / April 23, 2026 / Lexaria Bioscience Corp. (N
PIONEER TEENS is the first clinical trial of an oral GLP-1 in children & adolescents 10–17 years with type 2 diabetes, addressing a significant unmet need
Eli Lilly Is More Than GLP-1 Drugs. The Stock Looks Attractive.
02:42pm, Wednesday, 22'nd Apr 2026
The acquisition of Kelonia Therapeutics, announced this week, is part of Lilly's expansion into cancer treatments.
Ceasefire extension, Best Buy's new CEO, Amazon's GLP-1 push and more in Morning Squawk
08:22am, Wednesday, 22'nd Apr 2026
Here are five key things investors need to know to start the trading day.
Amazon.com to Offer Program for GLP-1 Weight-Loss Drugs
03:33pm, Tuesday, 21'st Apr 2026
Amazon One Medical members can get Novo Nordisk's Wegovy and Eli Lilly's Foundayo GLP-1 pills in a program that integrates primary-care services with the technology company's pharmacy business.
Amazon shakes GLP-1 race as Eli Lilly, Novo Nordisk stocks fall
03:31pm, Tuesday, 21'st Apr 2026
Amazon is expanding its footprint in healthcare, unveiling a new program aimed at simplifying access to weight-loss treatments and reshaping how GLP-1 drugs are delivered to patients. The move positio
Health insurers raise questions about Medicare program that will offer GLP-1s to seniors for $50
01:54pm, Tuesday, 21'st Apr 2026
Some health insurers are pushing back against a new program that will allow Medicare beneficiaries to pay $50 per month for GLP-1 medications for weight loss.
